Lupus & antiphospholipid syndrome

Renal tubular and glomerular estrogen receptor ß levels are lower in lupus nephritis than in familial Mediterranean fever-associated renal amyloidosis

LupusPublished Retrospective cohort study

Authors' conclusion

This study showed that tubular estrogen receptor ß expression score was elevated in familial Mediterranean fever amyloidosis and correlated with serum creatinine levels and renal crescents.

Study context

Population
Patients with LN, FMF amyloidosis or ANCA-associated glomerulonephritis and individuals with normal renal histology
Participants
30 / 12 / 10 / 14
Exposure
Renal estrogen receptor expression in LN vs FMF-associated renal amyloidosis vs ANCA-associated nephritis vs normal renal histology
  • Lupus nephritisn = 30
  • FMF amyloidosisn = 12reference
  • ANCAn = 10
  • Normal renal histologyn = 14
Outcome
Tubular estrogen receptor ß expression score

Main finding

As reported in the abstract

FMF amyloidosis

5

range 1–8

Lupus nephritis

0

range 0–1

ANCA

4

range 1–6.5

Odds ratio (95% CI)P value
FMF amyloidosisvs Lupus nephritisB = 1.385
3.996(1.805–8.846)
P = 0.001
FMF amyloidosis vs ANCA · B = −1.431
OR 0.239 (95% CI 0.093–0.614); P = 0.003

Observational data: associations, not effects.

Further findings

Correlation of serum creatinine with tubular estrogen receptor ß expression score

OR
0.565
95% CI
0.622-1.402
P
P < 0.0001

ANCA-associated glomerulonephritis: fibro cellular crescents and glomerular estrogen receptor ß expression score

OR
0.247
95% CI
0.11-0.999
P
P = 0.045

ANCA-associated glomerulonephritis: fibro cellular crescents and tubular estrogen receptor ß expression score

OR
0.282
95% CI
−0.180-2.812
P
P = 0.026

Original publication

Renal tubular and glomerular estrogen receptor ß levels are lower in lupus nephritis than in familial Mediterranean fever-associated renal amyloidosis. Lupus. Published 31 October 2023. doi:10.1177/09612033231210728

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.